Determination of the most appropriate method for extrapolating overall survival data from a placebo-controlled clinical trial of lenvatinib for progressive, radioiodine-refractory differentiated thyroid cancer.
about
Determination of the most appropriate method for extrapolating overall survival data from a placebo-controlled clinical trial of lenvatinib for progressive, radioiodine-refractory differentiated thyroid cancer.
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Determination of the most appr ...... differentiated thyroid cancer.
@ast
Determination of the most appr ...... differentiated thyroid cancer.
@en
type
label
Determination of the most appr ...... differentiated thyroid cancer.
@ast
Determination of the most appr ...... differentiated thyroid cancer.
@en
prefLabel
Determination of the most appr ...... differentiated thyroid cancer.
@ast
Determination of the most appr ...... differentiated thyroid cancer.
@en
P2093
P2860
P356
P1476
Determination of the most appr ...... differentiated thyroid cancer
@en
P2093
Christopher Livings
Gabriel Tremblay
Lydia Crowe
Venediktos Kapetanakis
P2860
P304
P356
10.2147/CEOR.S107498
P407
P577
2016-06-30T00:00:00Z